GlassScriptPhysician profile
Taeho Kim
NPI 1245751775
$1,505.25
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $731 · 2023: $456 · 2024: $61.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $404.03 | 2021-2023 | Relistor |
| Boston Scientific Corporation | $372.70 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $217.84 | 2022-2023 | Nalu Neurostimulation System |
| Depuy Synthes Products, INC. | $192.25 | 2022 | |
| Collegium Pharmaceutical, INC. | $116.43 | 2021-2022 | |
| Redhill Biopharma INC. | $42.14 | 2022 | |
| Stimwave Technologies Incorporated | $28.75 | 2022 | |
| Ibsa Pharma INC. | $27.18 | 2021-2022 | |
| Relievant Medsystems, INC. | $25.73 | 2023 | Intracept |
| Abbott Laboratories | $23.31 | 2023 | Proclaim |
| Medtronic, INC. | $21.23 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.44 | 2021 | |
| Athena Bioscience, LLC | $16.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taeho Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.